Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Atherosclerosis. 2009 Dec 5;210(2):555–562. doi: 10.1016/j.atherosclerosis.2009.12.002

Table 4.

Fasting lipoprotein-related parameters and hsCRP concentration at the end of experimental diet phases.

Low Lys:Arg High Lys:Arg P value
Total cholesterol (mg/dL) 207 ± 24 210 ± 27 0.236
LDL cholesterol (mg/dL) 137 ± 19 138 ± 22 0.593
VLDL cholesterol (mg/dL)# 15 ± 9 16 ± 10 0.189
HDL cholesterol (mg/dL) 55 ± 13 57 ± 13 0.133
Triglyceride (mg/dL)* 104 ± 35 109 ± 42 0.317
Total cholesterol:HDL cholesterol# 3.89 ± 0.85 3.86 ± 0.86 0.741
Lipoprotein (a) (mg/dL) #; 35.6 ± 25.3 35.6 ± 26.3 0.63
Apoprotein AI (mg/dL) 148.7 ± 22.8 152.7 ± 22.3 0.003
Apoprotein B (mg/dL) 101.5 ± 14.5 103.0 ± 15.8 0.267
sdLDL cholesterol (mg/dL) 36.1 ± 10.2 34.1 ± 9.3 0.152
RemLC (mg/dL) 5.99 ± 3.36 5.77 ± 2.60 0.601
hsCRP (mg/dL) 1.87 ± 2.45 2.44 ± 3.14 0.020
Glycated Albumin (%)# 13.6 ± 0.95 13.6 ± 0.9 0.863
Adiponectin (µg/mL)* 12.4 ± 6.58 11.6 ± 5.4 0.035
Immunoreactive Insulin (µU/mL)* 9.90 ± 3.96 10.8 ± 5.9 0.076
LCAT (µmol chol • L−1 • h−1)* 48.0 ± 15.5 49.2 ± 13.9 0.647
CETP (µmol chol • L−1 • h−1) 33.2 ± 19.4 32.6 ± 17.6 0.931
Cholesterol FSR (%/day) 7.48 ± 2.28 7.89 ± 2.04 0.406

A paired t-test was carried out for each variable.

*

Transformed to log10 values before statistical analysis.

#

Transformed to rank data before statistical analysis.